GLP-1 drugs linked to fewer psychiatric crises in schizophrenia and diabetes
Observational US data link GLP-1 receptor agonists with fewer psychiatric hospital admissions and emergency visits in schizophrenia plus type 2 diabetes.
This section contains the website’s posts.